Karam Mounzer

6.1k total citations
117 papers, 3.0k citations indexed

About

Karam Mounzer is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Karam Mounzer has authored 117 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Virology, 67 papers in Infectious Diseases and 32 papers in Epidemiology. Recurrent topics in Karam Mounzer's work include HIV Research and Treatment (71 papers), HIV/AIDS drug development and treatment (51 papers) and HIV/AIDS Research and Interventions (43 papers). Karam Mounzer is often cited by papers focused on HIV Research and Treatment (71 papers), HIV/AIDS drug development and treatment (51 papers) and HIV/AIDS Research and Interventions (43 papers). Karam Mounzer collaborates with scholars based in United States, United Kingdom and Canada. Karam Mounzer's co-authors include Luis J. Montaner, Jay R. Kostman, Emmanouil Papasavvas, Livio Azzoni, Jihed Chehimi, Mark J. DiNubile, Pablo Tebas, Ian Frank, Robert Gross and Giorgio Trinchieri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Karam Mounzer

107 papers receiving 3.0k citations

Peers

Countries citing papers authored by Karam Mounzer

Since Specialization

Citations

This map shows the geographic impact of Karam Mounzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karam Mounzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karam Mounzer more than expected).

Fields of papers citing papers by Karam Mounzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karam Mounzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karam Mounzer. The network helps show where Karam Mounzer may publish in the future.

Co-authorship network of co-authors of Karam Mounzer

This figure shows the co-authorship network connecting the top 25 collaborators of Karam Mounzer. A scholar is included among the top collaborators of Karam Mounzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karam Mounzer. Karam Mounzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Étude de phase 2 évaluant l'association BIC + LEN en prise orale quotidienne chez des personnes ayant un traitement du VIH par plusieurs comprimés 2024 ·Karam Mounzer, Jihad Slim, Moti Ramgopal, (unknown), (unknown), (unknown), (unknown), (unknown), Priyanka Arora, (unknown), Hal Martin, Peter Sklar, (unknown), Jared M. Baeten, Sorana Segal‐Maurer	1
2	Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy 2024 ·Immunity ·(unknown), Filippo Dragoni, (unknown), Fengting Wu, Jun Lai, Hao Zhang, James R. White, Rebecca Hoh, Kenneth Lynn, Pablo Tebas, Karam Mounzer, Steven G. Deeks, Luis J. Montaner, Janet D. Siliciano, Robert F. Siliciano, Francesco R. Simonetti	1
3	Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex HIV Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1) 2024 ·Clinical Infectious Diseases ·Karam Mounzer, Jihad Slim, Moti Ramgopal, (unknown), (unknown), Jorge Santana‐Bagur, (unknown), Ying Guo, Priyanka Arora, (unknown), Peter Sklar, Jared M. Baeten, Sorana Segal‐Maurer	3
4	1592. Real-World Utilization and Effectiveness of Long-Acting Cabotegravir + Rilpivirine Among People with HIV with Detectable Viral Loads at Initiation: Trio Cohort Study 2023 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), Gayathri Sridhar, Supriya Sarkar, Joseph J. Eron, Karam Mounzer, (unknown), Vani Vannappagari	5
5	Immune response to ART initiation in advanced HIV infection 2023 ·HIV Medicine ·Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R. McNicholl, (unknown), Michael Sension, Lewis McCurdy, Gregory Fusco	8
6	Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States 2023 ·SHILAP Revista de lepidopterología ·Andrea Bilger, (unknown), Frances K. Barg, Katharine A. Rendle, (unknown), (unknown), Nora L. Jones, (unknown), John A. Sauceda, Pablo Tebas, Karam Mounzer, David S. Metzger, Luis J. Montaner, Karine Dubé	12
7	HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant Gnidia sericocephala (Thymelaeaceae) 2022 ·Viruses ·(unknown), (unknown), (unknown), Thomas Klimkait, (unknown), Phanankosi Moyo, (unknown), (unknown), (unknown), (unknown), (unknown), Karam Mounzer, (unknown), (unknown), Nceba Gqaleni, Ian Tietjen, Luis J. Montaner, Vinesh Maharaj	7
8	Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens 2022 ·Open Forum Infectious Diseases ·Karam Mounzer, Laurence Brunet, Jennifer S Fusco, Ian R. McNicholl, Helena Díaz-Cuervo, Michael Sension, Lewis McCurdy, Gregory Fusco	23
9	Excessive Weight Gain: Current Antiretroviral Agents in Virologically Suppressed People with HIV 2022 ·AIDS Research and Human Retroviruses ·(unknown), Laurence Brunet, Jennifer S Fusco, Karam Mounzer, Joyce LaMori, Gregory Fusco	3
10	Weight gain before and after switch from TDF to TAF in a U.S. cohort study 2021 ·Journal of the International AIDS Society ·Patrick Mallon, Laurence Brunet, (unknown), Jennifer S Fusco, Karam Mounzer, Girish Prajapati, A Beyer, Michael Wohlfeiler, Gregory Fusco	95
11	Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV 2021 ·Nature Communications ·Leila B. Giron, Clovis S. Palmer, Qin Liu, Xiangfan Yin, Emmanouil Papasavvas, Radwa Sharaf, Behzad Etemad, Mohammad Damra, Aaron R. Goldman, Hsin‐Yao Tang, Rowena Johnston, Karam Mounzer, Jay R. Kostman, Pablo Tebas, Alan Landay, Luis J. Montaner, Jeffrey M. Jacobson, Jonathan Z. Li, Mohamed Abdel‐Mohsen	37
12	Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States 2021 ·AIDS Research and Human Retroviruses ·Karam Mounzer, Laurence Brunet, Ricky Hsu, Jennifer S Fusco, Vani Vannappagari, Cassidy Henegar, Jean van Wyk, (unknown), Janet Lo, Gregory Fusco	11
13	Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort 2021 ·AIDS Patient Care and STDs ·Karam Mounzer, Jennifer S Fusco, (unknown), Laurence Brunet, Vani Vannappagari, Kevin R. Frost, Mark S. Shaefer, Alex R. Rinehart, (unknown), Gregory Fusco	7
14	Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1 2020 ·Proceedings of the National Academy of Sciences ·Lynn N. Bertagnolli, Joseph Varriale, (unknown), (unknown), Francesco R. Simonetti, Jennifer A. White, Subul Beg, Kenneth Lynn, Karam Mounzer, Ian Frank, Pablo Tebas, Katharine J. Bar, Luis J. Montaner, Robert F. Siliciano, Janet D. Siliciano	46
15	No differences in delay discounting between smokers with and without HIV 2020 ·Psychopharmacology ·(unknown), (unknown), E. Paul Wileyto, Robert A. Schnoll, David Metzger, Frank T. Leone, Karam Mounzer, Robert Gross, Rebecca L. Ashare	2
16	Validation of the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) chronic kidney disease risk score in HIV‐infected patients in the USA 2020 ·HIV Medicine ·(unknown), (unknown), (unknown), Laurence Brunet, Ricky Hsu, A Beyer, Girish Prajapati, Karam Mounzer, (unknown)	4
17	Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial 2020 ·AIDS Research and Human Retroviruses ·Emmanouil Papasavvas, Livio Azzoni, Amélie Pagliuzza, Mohamed Abdel‐Mohsen, Brian N. Ross, (unknown), Bonnie J. Howell, Daria J. Hazuda, Nicolas Chomont, Qingsheng Li, Karam Mounzer, Jay R. Kostman, Pablo Tebas, Luis J. Montaner	8
18	Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV 2019 ·Drug and Alcohol Dependence ·Rebecca L. Ashare, (unknown), Katrina J. Serrano, Frank T. Leone, David S. Metzger, Ian Frank, Robert Gross, Anita Hole, Karam Mounzer, Ronald G. Collman, E. Paul Wileyto, Robert A. Schnoll	35
19	Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database 2018 ·Therapeutic Advances in Drug Safety ·Ricky Hsu, Jennifer S Fusco, Cassidy Henegar, Karam Mounzer, Michael Wohlfeiler, Vani Vannappagari, Michael Aboud, Lloyd Curtis, Gregory Fusco	7
20	Relationship of Admission Plasma Gelsolin Levels to Clinical Outcomes in Patients after Major Trauma 1999 ·American Journal of Respiratory and Critical Care Medicine ·Karam Mounzer, Michael Moncure, (unknown), Mark J. DiNubile	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact